CLINICAL_TRIALS
trial_result
· 2015-03-27
Clinical Trial Update: Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia [Phase 2]
Summary
Phase 2 pilot trial evaluating erlotinib for de novo acute myeloid leukemia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Indiana University | Conditions: Leukemia, Myelomonocytic, Acute | Phase 2 | Status: COMPLETED | Results posted: 2015-03-27